OMEICOS Therapeutics' Grant - III Round

OMEICOS Therapeutics raised a round of funding on June 08, 2017. Investors include Bundesministerium fur Bildung und Forschung.

OMEICOS Therapeutics is a biopharmaceutical company developing small molecule therapeutics for the prevention and treatment of cardiovascular diseases. The company has discovered a series of metabolic…

Articles about OMEICOS Therapeutics' Grant - III Round: